Prot #RAIN-3201: A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma

Project: Research project

Project Details

StatusActive
Effective start/end date1/31/22 → 1/31/25

Funding

  • PSI Pharma Support America Inc. ((OE) Prot #RAIN-3201 // (OE) Prot #RAIN-3201)
  • Rain Therapeutics Inc. ((OE) Prot #RAIN-3201 // (OE) Prot #RAIN-3201)